Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950168-98-000958
Filing Date
1998-03-30
Accepted
1998-03-30 00:00:00
Documents
15
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 10-K FOR THE FISCAL YEAR ENDED 12/31/97 10-K 180697
2 AMENDED AND RESTATED BYLAWS EX-3.4 57268
3 LEASE FOR ROYAL CENTER II EX-10.9 123429
4 LEASE AND SERVICE AGREEMENT EX-10.34 6041
5 AMENDMENT TO TYSON AGREEMENT EX-10.35 2434
6 LIST OF SUBSIDIARIES EX-21 578
7 CONSENT OF INDEPENDENT AUDITORS EX-23 1303
8 POWER OF ATTORNEY EX-24 2774
9 EXHIBIT 27.1 EX-27 2122
10 EXHIBIT 27.2 EX-27.2 1721
11 EXHIBIT 27.3 EX-27.3 2030
12 EXHIBIT 27.4 - FINANCIAL DATA SCHEDULE EX-27.4 2206
13 EXHIBIT 27.5 EX-27.5 2228
14 EXHIBIT 27.6 EX-27.6 2217
15 RISK FACTORS EX-99 25876
  Complete submission text file 0000950168-98-000958.txt   415750
Mailing Address PO BOX 13989 RESEARCH TRIANGLE PK NC 27709
Business Address 1035 SWABIA COURT MORRISVILLE NC 27560 9199415185
EMBREX INC/NC (Filer) CIK: 0000878725 (see all company filings)

EIN.: 561469825 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19495 | Film No.: 98579833
SIC: 2836 Biological Products, (No Diagnostic Substances)